Work

Abstract 5532: Combinational targeted therapy effects on EphA2 and KRAS G12C inhibitor against KRAS G12C mutated non-small cell lung cancer cells

Year: 2025
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409630426
Cites:
Cited by:
Related to: 10